AI assistant
MACFARLANE GROUP PLC — Regulatory Filings 2019
Feb 25, 2019
4664_rns_2019-02-25_545c34b4-2afb-418c-a2e7-b372aad75e2d.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0369R
Macfarlane Group PLC
25 February 2019
25 February 2019
Macfarlane Group PLC
Change of registered office
Macfarlane Group PLC announces that it has changed its Glasgow headquarters and registered office address with immediate effect to:
3 Park Gardens,
Glasgow,
G3 7YE
| ## Further enquiries: | ## Macfarlane Group | Tel: 0141 333 9666 |
| Peter Atkinson Chief Executive | ||
| John Love Finance Director | ||
| ## Spreng Thomson | Tel: 0141 548 5191 | |
| Callum Spreng | Mob: 07803 970103 |
Legal Entity Identifier (LEI): 213800LVRYDERSJAAZ73
Notes to Editors:
· Macfarlane Group PLC is listed on the London Stock Exchange (LSE: MACF) in the Industrials Sector
· The company is headquartered in Glasgow, Scotland and has more than 60 years' experience in the UK packaging industry
· Macfarlane Group's businesses are:
o Macfarlane Packaging is the leading UK distributor of a comprehensive range of protective packaging products
o Labels designs and prints high quality self-adhesive and resealable labels, principally for FMCG companies
o Packaging Design and Manufacture designs and produces protective packaging for high value, fragile products
· Macfarlane Group employs over 900 people at 30 sites, principally in the UK, but also in Ireland and Sweden.
The company has 20,000+ customers in the UK, Europe and the USA providing 600,000+ lines to a wide range of industry sectors including: consumer goods; food manufacturing; logistics; internet retail; mail order; electronics; defence and aerospace.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
CROGMGZZFKRGLZM